[3H]QNB displays in vivo selectivity for the m2 subtype
- 1 January 1994
- journal article
- research article
- Published by Elsevier in Life Sciences
- Vol. 55 (19), 1493-1508
- https://doi.org/10.1016/0024-3205(94)00691-1
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Therapeutic potential of CNS-active M2 antagonists: Novel structures and pharmacologyLife Sciences, 1993
- A novel m2-selective muscarinic antagonist: binding characteristics and autoradiographic distribution in rat brainBrain Research, 1992
- Comparative Alterations of Nicotinic and Muscarinic Binding Sites in Alzheimer's and Parkinson's DiseasesJournal of Neurochemistry, 1992
- The Distribution of Cerebral Muscarinic Acetylcholine Receptors In Vivo in Patients With DementiaArchives of Neurology, 1991
- Quantitative autoradiography of M2 muscarinic receptors in the rat brain identified by using a selective radioligand [3H]AF-DX 116Brain Research, 1989
- Quantitative autoradiographic distribution of [3H]AF-DX 116 muscarinic-M2 receptor binding sites in rat brainSynapse, 1989
- Differential Alteration of Various Cholinergic Markers in Cortical and Subcortical Regions of Human Brain in Alzheimer's DiseaseJournal of Neurochemistry, 1988
- Distribution of muscarinic receptor subtypes in rat brain as determined in binding studies with AF-DX 116 and pirenzepineLife Sciences, 1987
- Muscarinic acetylcholine receptors in Alzheimer's disease. In vivo imaging with iodine 123-labeled 3-quinuclidinyl-4-iodobenzilate and emission tomographyJAMA, 1985
- Loss of M2 Muscarine Receptors in the Cerebral Cortex in Alzheimer's Disease and Experimental Cholinergic DenervationScience, 1985